510(k) Report

FDA applicant

Graftworx, Inc. Dba Alio

San Francisco, CA1 decision2022–20220 recalls

FDA records 1 decision for Graftworx, Inc. Dba Alio (San Francisco, CA) in 2022: 1 510(k) clearance. All are in product code DRG (Transmitters And Receivers, Physiological…). Its devices cite 1 predicate, 0 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Graftworx, Inc. Dba Alio’s devices, and how often a recall has named them.

FDA decisions per year

1in 2022

2022: 1
2022high 1 (2022) · low 0 (2023)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2022.

FIG. 1 — Graftworx, Inc. Dba Alio by year, 2022–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Graftworx, Inc. Dba Alio’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report